Abstract
Background and objectivesEndophthalmitis is a type of eye inflammation that affects all structures of the eye and is generally of infectious origin. In cases recalcitrant to intravitreal treatment or posterior vitrectomy, evisceration or enucleation are the preferable options. Polymethylmethacrylate (PMMA) bone cement has stood out as an implant in other areas of medicine due to its great stability and healing. In this study, we will evaluate the safety and extrusion rate of the antibiotic-reinforced bone cement implant when it is decided to place it at the same surgical time as an evisceration indicated for infective endophthalmitis. Materials and methodsSubjects of any age and gender from the Oculoplastic outpatient clinic of the Instituto de Oftalmología Fundación Conde de Valenciana, with a diagnosis of infectious endophthalmitis who required evisceration between the months of May and October 2012, were included. Results20 subjects were included, of which 55% (11) were men, and 45% (9) women, with an average age range of 51 to 80years. No complications were evidenced in the immediate postoperative period or in the follow-up of 1, 3 and 6months, and in all cases, the correct position of the implant was confirmed with computed tomography. ConclusionsIn patients diagnosed with infectious endophthalmitis of any cause, evisceration and implantation of bone cement in a single surgical time is a safe and effective option.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.